JP2015513552A5 - - Google Patents

Download PDF

Info

Publication number
JP2015513552A5
JP2015513552A5 JP2014560334A JP2014560334A JP2015513552A5 JP 2015513552 A5 JP2015513552 A5 JP 2015513552A5 JP 2014560334 A JP2014560334 A JP 2014560334A JP 2014560334 A JP2014560334 A JP 2014560334A JP 2015513552 A5 JP2015513552 A5 JP 2015513552A5
Authority
JP
Japan
Prior art keywords
dihydro
benzyl
benzodioxin
dioxino
pyridin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014560334A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015513552A (ja
JP6080226B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/054381 external-priority patent/WO2013131901A1/en
Publication of JP2015513552A publication Critical patent/JP2015513552A/ja
Publication of JP2015513552A5 publication Critical patent/JP2015513552A5/ja
Application granted granted Critical
Publication of JP6080226B2 publication Critical patent/JP6080226B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014560334A 2012-03-06 2013-03-05 他の活性物質と組み合わせたロイコトリエン産生阻害用ベンゾジオキサン Active JP6080226B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261607149P 2012-03-06 2012-03-06
US61/607,149 2012-03-06
PCT/EP2013/054381 WO2013131901A1 (en) 2012-03-06 2013-03-05 Benzodioxanes in combination with other actives for inhibiting leukotriene production

Publications (3)

Publication Number Publication Date
JP2015513552A JP2015513552A (ja) 2015-05-14
JP2015513552A5 true JP2015513552A5 (cg-RX-API-DMAC10.html) 2016-04-21
JP6080226B2 JP6080226B2 (ja) 2017-02-15

Family

ID=47833062

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014560334A Active JP6080226B2 (ja) 2012-03-06 2013-03-05 他の活性物質と組み合わせたロイコトリエン産生阻害用ベンゾジオキサン

Country Status (16)

Country Link
US (1) US9662339B2 (cg-RX-API-DMAC10.html)
EP (1) EP2822941B1 (cg-RX-API-DMAC10.html)
JP (1) JP6080226B2 (cg-RX-API-DMAC10.html)
KR (1) KR20140138851A (cg-RX-API-DMAC10.html)
CN (1) CN104487435A (cg-RX-API-DMAC10.html)
AR (1) AR090259A1 (cg-RX-API-DMAC10.html)
AU (1) AU2013229560A1 (cg-RX-API-DMAC10.html)
CA (1) CA2866471A1 (cg-RX-API-DMAC10.html)
CL (1) CL2014002326A1 (cg-RX-API-DMAC10.html)
EA (1) EA201400976A1 (cg-RX-API-DMAC10.html)
MX (1) MX2014010563A (cg-RX-API-DMAC10.html)
NZ (1) NZ628587A (cg-RX-API-DMAC10.html)
PH (1) PH12014501967A1 (cg-RX-API-DMAC10.html)
TW (1) TW201350475A (cg-RX-API-DMAC10.html)
UY (1) UY34661A (cg-RX-API-DMAC10.html)
WO (1) WO2013131901A1 (cg-RX-API-DMAC10.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012125598A1 (en) 2011-03-14 2012-09-20 Boehringer Ingelheim International Gmbh Benzodioxane inhibitors of leukotriene production
US9139567B2 (en) 2011-07-19 2015-09-22 Boehringer Ingelheim International Gmbh Arylpyrazole ethers as inhibitors of leukotriene A4 hydrolase
NZ628587A (en) 2012-03-06 2016-07-29 Boehringer Ingelheim Int Benzodioxanes in combination with other actives for inhibiting leukotriene production
US8946203B2 (en) 2012-03-06 2015-02-03 Boehringer Ingelheim International Gmbh Benzodioxane inhibitors of leukotriene production
US9255154B2 (en) 2012-05-08 2016-02-09 Alderbio Holdings, Llc Anti-PCSK9 antibodies and use thereof
WO2014014874A1 (en) 2012-07-17 2014-01-23 Boehringer Ingelheim International Gmbh Pyrazole derivatives which inhibit leukotriene production
JP6449235B2 (ja) 2013-03-27 2019-01-09 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 治療に対する応答性を予測するための遺伝マーカー
US9303018B2 (en) 2013-07-15 2016-04-05 Boehringer Ingelheim International Gmbh Inhibitors of leukotriene production
JP2016523982A (ja) 2013-07-15 2016-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ロイコトリエン生成の阻害剤
PT3174995T (pt) 2014-07-30 2020-10-15 Hoffmann La Roche Marcadores genéticos para prever o tipo de resposta ao tratamento com um fármaco de aumento do hdl ou mimetizador do hdl
WO2016022742A1 (en) * 2014-08-08 2016-02-11 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds
CN104181252B (zh) * 2014-09-01 2015-12-02 广东东阳光药业有限公司 一种分离检测安塞曲匹及其异构体的方法
CN105748469B (zh) * 2016-02-24 2019-07-23 长沙佰顺生物科技有限公司 一种安塞曲匹辛伐他汀药物组合物
JP6832342B2 (ja) * 2016-03-31 2021-02-24 武田薬品工業株式会社 複素環化合物
AU2021325431B2 (en) 2020-08-14 2024-01-18 Novartis Ag Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof
CN112076189B (zh) * 2020-09-23 2021-11-12 唐怡庭 一种酰胺化合物在制备治疗脓毒症药物中的应用
EP4426284A4 (en) 2021-11-01 2025-11-12 Alkahest Inc Benzodioxane Leukotriene A4 Hydrolase (LTA4H) Modulators for the Prevention and Treatment of Age-Related Diseases

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US498770A (en) * 1893-06-06 Electrolytic apparatus
US4918092A (en) * 1983-12-21 1990-04-17 Merck Frosst Canada, Inc. Leukotriene antagonists
US5120758A (en) * 1991-02-08 1992-06-09 Ciba-Geigy Corporation Certain benzodioxole, benzodioxane and benzodioxepin derivatives useful as 5-lipoxygenase inhibitors
DE4127849A1 (de) 1991-08-22 1993-02-25 Merck Patent Gmbh Benzodioxanderivate
US6506876B1 (en) 1994-10-11 2003-01-14 G.D. Searle & Co. LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use
US5585492A (en) * 1994-10-11 1996-12-17 G. D. Searle & Co. LTA4 Hydrolase inhibitors
DE19705450A1 (de) 1997-02-13 1998-08-20 Merck Patent Gmbh Bicyclische aromatische Aminosäuren
DE19821003A1 (de) 1998-05-11 1999-11-18 Dresden Arzneimittel Neue 1,2,5-trisubstituierte 1,2-dihydro-indazol-3-one mit antiasthmatischer, antiallergischer, entzündungshemmender, immunmodulierender und neuroprotektiver Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
SK4872003A3 (en) 2000-10-26 2004-08-03 Pfizer Prod Inc Metaloproteinase pyrimidine-2,4,6-trione inhibitors
US20060019269A1 (en) * 2002-10-17 2006-01-26 Decode Genetics, Inc. Susceptibility gene for myocardial infarction, stroke, and PAOD, methods of treatment
EP2186516B1 (en) 2002-12-20 2013-01-16 Glaxo Group Limited Novel benzazepine derivative
US7098222B2 (en) 2004-05-12 2006-08-29 Abbott Laboratories Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
BRPI0518508A2 (pt) 2005-01-07 2008-11-25 Pfizer Prod Inc compostos de quinolina heteroaromÁticos e seu uso como inibidores de pde10
EP1868605A2 (en) 2005-03-31 2007-12-26 Janssen Pharmaceutica, N.V. Phenyl and pyridyl lta4h modulators
NZ566788A (en) 2005-09-21 2012-10-26 Decode Genetics Ehf Biaryl substituted heterocycle inhibitors of LTA4H for treating inflammation
WO2007073405A1 (en) 2005-12-21 2007-06-28 Decode Genetics Ehf N-linked aryl heteroaryl inhibitors of lta4h for treating inflammation
EP1968961A2 (en) 2005-12-21 2008-09-17 Decode Genetics EHF Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation
WO2008052086A1 (en) 2006-10-24 2008-05-02 Wyeth Benzodioxane derivatives and uses thereof
BRPI0911336A2 (pt) 2008-04-11 2021-06-29 Janssen Pharmaceutica N.V. tiazolopiridin-2-iloxifenil e tiazolopirazin-2-iloxifenil aminas como moduladores de leucotrieno a4 hidrolase
NZ596213A (en) 2009-04-08 2013-05-31 Actelion Pharmaceuticals Ltd 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines as adenosine 5'-diphosphate (ADP) receptor antagonists
EP2475666A2 (en) 2009-09-11 2012-07-18 Trius Therapeutics, Inc. Gyrase inhibitors
CN102946877B (zh) 2010-03-18 2019-07-05 香港科技大学 乳突果及其分离的化合物在制备用于治疗神经疾病的药物中的用途
WO2012125598A1 (en) * 2011-03-14 2012-09-20 Boehringer Ingelheim International Gmbh Benzodioxane inhibitors of leukotriene production
US9139567B2 (en) 2011-07-19 2015-09-22 Boehringer Ingelheim International Gmbh Arylpyrazole ethers as inhibitors of leukotriene A4 hydrolase
US8946203B2 (en) 2012-03-06 2015-02-03 Boehringer Ingelheim International Gmbh Benzodioxane inhibitors of leukotriene production
NZ628587A (en) 2012-03-06 2016-07-29 Boehringer Ingelheim Int Benzodioxanes in combination with other actives for inhibiting leukotriene production
WO2014014874A1 (en) 2012-07-17 2014-01-23 Boehringer Ingelheim International Gmbh Pyrazole derivatives which inhibit leukotriene production

Similar Documents

Publication Publication Date Title
JP2015513552A5 (cg-RX-API-DMAC10.html)
US9662339B2 (en) Benzodioxane inhibitors of leukotriene production for combination therapy
US8946203B2 (en) Benzodioxane inhibitors of leukotriene production
US11878975B2 (en) Substituted indole compounds useful as TLR inhibitors
JP7313354B2 (ja) Tlr阻害剤として有用なアミド置換されたインドール化合物
US9403830B2 (en) Inhibitors of leukotriene production
JP5630867B2 (ja) イミダゾピリジン−2−オン誘導体
JP2015512888A5 (cg-RX-API-DMAC10.html)
JP2004507442A5 (cg-RX-API-DMAC10.html)
RU2002118622A (ru) Гетероциклические дигидропиримидиновые соединения
JPWO2005063743A1 (ja) チアゾール誘導体
JP2011500774A5 (cg-RX-API-DMAC10.html)
DK1921077T3 (en) Means for treating and / or preventing sleep disorders
JP2017531672A5 (cg-RX-API-DMAC10.html)
RU2007101501A (ru) Аридзамещенные пиперазиновые производные
WO2011096490A1 (ja) イミダゾピリジン-2-オン誘導体
JP2011178779A (ja) イミダゾピリジン−2−オン誘導体
WO2026017844A1 (en) Combination therapies comprising a mettl3 inhibitor and a bcl2 inhibitor
EP4479135A1 (en) Substituted imidazopyridinyl compounds useful as inhibitors of tlr9
JP2025538181A (ja) Tlr9の阻害剤として有用な置換されたベンズイミダゾール化合物